查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1361754

全球人工智慧 (AI) 藥物發現市場報告

Global Artificial Intelligence (AI) in Drug Discovery Market Report
出版日期: | 出版商: Value Market Research | 英文 286 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年，全球藥物發現市場對人工智慧（AI）的需求將從2022年的11.9億美元達到近272.5億美元的市場規模，2023年至2030年的研究期間年複合成長率為47.9%。

藥物發現中的人工智慧（AI）是一種利用機器模擬人類智慧來解決藥物發現過程中具有挑戰性問題的技術。該技術有助於發現新化合物，並有助於識別治療標靶和開發定製藥物。該系統有許多應用，包括深入了解藥物識別和減輕各種慢性疾病的嚴重程度。該市場包括用於藥物發現銷售和相關服務的人工智慧。

市場動態：

推動人工智慧在藥物輸送市場成長的一些主要促進因素包括基於雲端的應用程式和服務的使用不斷增加以及重磅藥品的專利即將到期。推動需求的其他因素包括控制藥物發現成本的需求不斷成長以及藥物開發所需時間的減少。此外，由於新型藥物療法的發現和開發以及生命科學產業製造能力的不斷擴大，技術需求也在不斷成長。然而，預計未來幾年，一些問題將阻礙該行業的發展，包括缺乏熟練的人工智慧工人、醫療軟體的監管要求不明確以及該領域缺乏資料集。儘管如此，跨產業合作的日益頻繁將成為影響市場發展速度的主要驅動力。

該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對藥物發現領域人工智慧 (ai) 全球市場的各個細分市場進行了包容性評估。人工智慧 (AI) 在藥物發現行業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲藥物發現市場對人工智慧 (AI) 的當前和未來需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。藥物發現市場人工智慧（ai）的主要參與者包括微軟公司（美國）、Exscientia（英國）、NVIDIA公司（美國）、薛丁格（美國）、Atomwise公司（美國）、BenevolentAI（英國）、 NuMedii（美國） 、Google（美國）、Insilico Medicine（美國）、BERG LLC（美國）、Cloud Pharmaceuticals（美國）、Cyclica（加拿大）、Deep Genomics（加拿大）、IBM（美國）、BIOAGE（美國）、Valo Health（美國） 、Envisagenics（美國）、twoXAR（美國）、XtalPi（美國）、Verge Genomics（美國）、Owkin, Inc.（美國）、Biovista（美國）、Evaxion Biotech（丹麥）、Iktos（法國）、 Standigm（韓國）和BenchSci（加拿大）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：藥物發現中的人工智慧 (AI) - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品提供的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：藥物發現市場分析中的全球人工智慧 (AI)：透過提供

  • 按產品分類概述
  • 歷史和預測數據
  • 按產品分析
  • 軟體
  • 服務

第 6 章：藥物發現市場分析中的全球人工智慧 (AI)：按技術分類

  • 依技術概述
  • 歷史和預測數據
  • 依技術分析
  • 機器學習
  • 深度學習
  • 監督學習
  • 強化學習
  • 無監督學習
  • 其他機器學習技術
  • 其他技術

第 7 章：藥物發現市場分析中的全球人工智慧 (AI)：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：藥物發現公司中人工智慧 (AI) 的競爭格局

  • 藥物發現市場競爭中的人工智慧（Ai）
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Microsoft Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Exscientia (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • NVIDIA Corporation (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Schrodinger (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Atomwise Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BenevolentAI (UK)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • NuMedii (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Google (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Insilico Medicine (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BERG LLC (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cloud Pharmaceuticals (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cyclica (Canada)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Deep Genomics (Canada)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • IBM (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BIOAGE (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Valo Health (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Envisagenics (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • twoXAR (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • XtalPi (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Verge Genomics (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Owkin Inc. (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biovista (US)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Evaxion Biotech (Denmark)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Iktos (France)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Standigm (South Korea)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • BenchSci (Canada)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11218721

The global demand for Artificial Intelligence (AI) in Drug Discovery Market is presumed to reach the market size of nearly USD 27.25 BN by 2030 from USD 1.19 BN in 2022 with a CAGR of 47.9% under the study period of 2023 - 2030.

Artificial intelligence (AI) in Drug Discovery is a technology that employs machines to simulate human intelligence to solve challenging issues in the drug discovery process. The technology helps in discovering novel compounds and aids in the identification of therapeutic targets and the development of tailored medications. The system has numerous applications, including deriving insights into identifying drugs and lessening the severity of various chronic diseases. This market includes AI for drug discovery sales and related services.

MARKET DYNAMICS:

Some of the main drivers propelling the growth of AI in the drug delivery market include the rising usage of cloud-based applications and services and the impending patent expiration of blockbuster pharmaceuticals. Additional factors boosting demand are the growing need to control drug discovery costs and less time required for drug development. Further, the technology demand is also rising due to the discovery and development of novel pharmacological therapies and the expanding manufacturing capabilities of the life science industry. However, several problems are anticipated to impede the growth of this industry in the years to come, including a lack of skilled AI workers, hazy regulatory requirements for medical software, and a lack of data sets in this area. Nonetheless, the growing frequency of cross-industry partnerships will be a major driver influencing the market's development rate.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence ( ai) in drug discovery. The growth and trends of Artificial Intelligence ( AI) in Drug Discovery Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence ( ai) in drug discovery market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Application

  • Immuno-Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers And Academic & Government Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence ( AI) in Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence ( ai) in drug discovery market include Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrodinger (US), Atomwise, Inc. (US), BenevolentAI (UK), NuMedii (US), Google (US), Insilico Medicine (US), BERG LLC (US), Cloud Pharmaceuticals (US), Cyclica (Canada), Deep Genomics (Canada), IBM (US), BIOAGE (US), Valo Health (US), Envisagenics (US), twoXAR (US), XtalPi (US), Verge Genomics (US), Owkin, Inc. (US), Biovista (US), Evaxion Biotech (Denmark), Iktos (France), Standigm (South Korea), and BenchSci (Canada). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Offering
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY OFFERING

  • 5.1 Overview by Offering
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Offering
  • 5.4 Software Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Machine Learning Historic and Forecast Sales by Regions
  • 6.5 Deep Learning Historic and Forecast Sales by Regions
  • 6.6 Supervised Learning Historic and Forecast Sales by Regions
  • 6.7 Reinforcement Learning Historic and Forecast Sales by Regions
  • 6.8 Unsupervised Learning Historic and Forecast Sales by Regions
  • 6.9 Other Machine Learning Technologies Historic and Forecast Sales by Regions
  • 6.10. Other Technologies Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY COMPANIES

  • 8.1. Artificial Intelligence (Ai) In Drug Discovery Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Microsoft Corporation (US)
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Exscientia (UK)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. NVIDIA Corporation (US)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Schrodinger (US)
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Atomwise Inc. (US)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. BenevolentAI (UK)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. NuMedii (US)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Google (US)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Insilico Medicine (US)
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. BERG LLC (US)
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Cloud Pharmaceuticals (US)
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Cyclica (Canada)
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Deep Genomics (Canada)
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. IBM (US)
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. BIOAGE (US)
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Valo Health (US)
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Envisagenics (US)
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. twoXAR (US)
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments
  • 9.21. XtalPi (US)
    • 9.21.1. Company Overview
    • 9.21.2. Company Revenue
    • 9.21.3. Products
    • 9.21.4. Recent Developments
  • 9.22. Verge Genomics (US)
    • 9.22.1. Company Overview
    • 9.22.2. Company Revenue
    • 9.22.3. Products
    • 9.22.4. Recent Developments
  • 9.23. Owkin Inc. (US)
    • 9.23.1. Company Overview
    • 9.23.2. Company Revenue
    • 9.23.3. Products
    • 9.23.4. Recent Developments
  • 9.24. Biovista (US)
    • 9.24.1. Company Overview
    • 9.24.2. Company Revenue
    • 9.24.3. Products
    • 9.24.4. Recent Developments
  • 9.25. Evaxion Biotech (Denmark)
    • 9.25.1. Company Overview
    • 9.25.2. Company Revenue
    • 9.25.3. Products
    • 9.25.4. Recent Developments
  • 9.26. Iktos (France)
    • 9.26.1. Company Overview
    • 9.26.2. Company Revenue
    • 9.26.3. Products
    • 9.26.4. Recent Developments
  • 9.27. Standigm (South Korea)
    • 9.27.1. Company Overview
    • 9.27.2. Company Revenue
    • 9.27.3. Products
    • 9.27.4. Recent Developments
  • 9.28. BenchSci (Canada)
    • 9.28.1. Company Overview
    • 9.28.2. Company Revenue
    • 9.28.3. Products
    • 9.28.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Artificial Intelligence (Ai) In Drug Discovery Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Artificial Intelligence (Ai) In Drug Discovery Report
  • Market Research Process
  • Market Research Methodology
  • Global Artificial Intelligence (Ai) In Drug Discovery Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Offering
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.